Search results

  1. Transforming Intermediate Care

    Shared learning database Organisation: Rochdale Infirmary, Northern Care Alliance Published date: March

  2. Encorafenib plus cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancer (TA668)

    Evidence-based recommendations on encorafenib (Braftovi) plus cetuximab (Erbitux) for treating BRAF V600E mutation-positive metastatic colorectal cancer in